- A specialist provider of clinical services to patients in their own homes, alleviating pressure on the NHS, freeing up vital bed space, saving time and reducing costs
- Funds will be used to expand this successful innovative solution across the UK and allow investment in Virtual Ward and telematic technologies
- HomeLink Healthcare can now scale their service to meet the needs of a rapidly growing market benefitting from significant industry tailwinds
Click here for the PDF Version.
London, 20 April 2022: Foresight Group LLP (“Foresight”), a leading listed infrastructure and SME investment manager, has made a £2.15m investment into HomeLink Healthcare Limited (“HomeLink” or “the Company”) from Foresight VCT and Foresight Enterprise VCT. Existing shareholders also invested £500,000 to further support HomeLink’s growth.
Formed in 2015, HomeLink has provided “hospital-at-home” services since 2018. The Company employs highly qualified and experienced nurses and rehabilitation teams to support the NHS - by providing services to patients in their own homes. These services deliver a range of clinical interventions, including wound care, intravenous therapies, physiotherapy, and rehabilitation. HomeLink has also expanded into the rapidly growing remote monitoring practice and offers a “virtual ward” solution.
Bed-blocking is an endemic issue across the NHS with significant delays in the discharge of patients and increasing hospital admissions due to a lack of viable alternatives. This is exacerbated by demographic shifts and the pandemic. HomeLink relieves these pressures by freeing up vital hospital bed space, providing a better experience for patients at home, reducing hospital admissions, and facilitating the efficient discharge of patients.
Demand for HomeLink’s services is forecast to grow significantly because of recent government initiatives around efficiency, the elective surgery backlog and NHS England, which has put in place a number of supportive measures. This includes increased funding for community care and virtual wards.
This funding will support the scaling of the business by expanding the clinical team, allowing HomeLink to meet the demands of clients and prospects. HomeLink will invest in supportive technologies and plans to expand outside its current geography into new hospitals and regions. The Company also aims to explore additional treatment pathways and grow its “virtual ward” offering.
Foresight is one of the UK’s most active investors in smaller companies. For close to four decades, Foresight has supported nearly 300 smaller companies through various economic cycles. Foresight partners with promising smaller companies across all sectors and deal stages to deliver long term sustainable growth and high-quality, local jobs.
Commenting on the investment, Jill Ireland, CEO and Clinical Director of HomeLink Healthcare, said: “We are delighted to be working with Foresight; their investment will create opportunities and allow development into new services and territories. It will also enable HomeLink to extend innovative clinical home care services. By working in partnership with the NHS, HomeLink will be able to care for more patients at home, freeing up hospital beds and provide the much-needed additional Hospital-at-Home services care, which will help to address inequalities in access to community-based care.”
Nick Mettyear, Senior Investment Manager at Foresight, added: “We are excited to be supporting HomeLink on the next phase of its growth journey. HomeLink’s quality of care is of the highest standard and provides patients with an improved service in the familiar surroundings of their own home. The team is well placed to provide mission-critical services to the NHS and help ease existing pressures in the NHS that have been exacerbated by the pandemic.”
Advisers to Foresight:
Financial DD: PKF Francis Clarke
Legal DD: RW Blears
Commercial DD: WhiteCap Consulting
Management DD: Catalysis
Cyber DD: KryptoKloud
Insurance DD: Lockton
For more information contact:
Borja Miquel: email@example.com / +44 (0)20 7025 6631
Lucy Sherwood : firstname.lastname@example.org / +44 (0)20 3667 8100
Notes to Editors
About Foresight Group LLP (“Foresight”):
Foresight Group was founded in 1984 and is a leading listed infrastructure and private equity investment manager. With a long-established focus on ESG and sustainability-led strategies, it aims to provide attractive returns to its institutional and private investors from hard-to-access private markets. Foresight manages over 300 infrastructure assets with a focus on solar and onshore wind assets, bioenergy, and waste, as well as renewable energy enabling projects, energy efficiency management solutions, social and core infrastructure projects and sustainable forestry assets. Its private equity team manages eight regionally focused investment funds across the UK, supporting over 130 SMEs. Its Foresight Capital Management team manages four funds with £1.5 billion Assets Under Management (AUM), investing in listed real assets with environmental and social benefits. Foresight operates from 12 offices across six countries in Europe and Australia with AUM of £8.7 billion as at 31 March 2022. Foresight Group Holdings Limited listed on the Main Market of the London Stock Exchange in February 2021.
About HomeLink Healthcare Limited
HomeLink Healthcare services support the transition from hospital to home-based care avoiding the need for people to be admitted to hospital and enabling others to come home more quickly. Ours is a service for the future of the health system, operating both within the NHS and for private health providers and patients.
We provide expert nursing and therapeutic care in the home, to complement and enhance existing hospital-based patient services. This makes healthcare systems more flexible, efficient and cost-effective. We focus on hiring the best specialist and multi-disciplinary staff and putting in place systems that deliver a responsive, patient-centred and clinically led service. Our commitment to staff wellbeing and applying new technologies supports this goal.